Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.

Jovanovic, Jv; Ivey, A; Vannucchi, ALESSANDRO MARIA; Lippert, E; Oppliger Leibundgut, E; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, Paola; van der Reijden BA,; Jansen, Jh; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; Mclornan, D; Yeoman, K; Akiki, S; Bryon, J; Jeffries, S; Jones, A; Percy, Mj; Schwemmers, S; Gruender, A; Kelley, Tw; Reading, S; Pancrazzi, Alessandro; Mcmullin, Mf; Pahl, Hl; Cross, Nc; Harrison, Cn; Prchal, Jt; Chomienne, C; Kiladjian, Jj; Barbui, T; Grimwade, D.

doi:10.1038/leu.2013.219

studio europeo per la standardizzazione della metodlogia molecolare pe rle mutazioni di jak2

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study / Jovanovic JV;Ivey A;Vannucchi AM;Lippert E;Oppliger Leibundgut E;Cassinat B;Pallisgaard N;Maroc N;Hermouet S;Nickless G;Guglielmelli P;van der Reijden BA;Jansen JH;Alpermann T;Schnittger S;Bench A;Tobal K;Wilkins B;Cuthill K;McLornan D;Yeoman K;Akiki S;Bryon J;Jeffries S;Jones A;Percy MJ;Schwemmers S;Gruender A;Kelley TW;Reading S;Pancrazzi A;McMullin MF;Pahl HL;Cross NC;Harrison CN;Prchal JT;Chomienne C;Kiladjian JJ;Barbui T;Grimwade D. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 27:(2013), pp. 2032-2039. [10.1038/leu.2013.219]